Advertisement

Clinical Drug Investigation

, Volume 11, Issue 2, pp 90–96 | Cite as

Effect of L-Carnitine on the Limitation of Infarct Size in One-Month Postmyocardial Infarction Cases

A Multicentre, Randomised, Parallel, Placebo-Controlled Trial
  • K. G. C. Jacoba
  • R. F. AbarquezJr
  • G. O. Topacio
  • M. T. Abola
  • V. B. Flores
  • J. M. Sison
  • V. Defensor
  • D. Aliwalas
Clinical Use

Summary

On the basis of biochemical, experimental and clinical studies reporting a favourable effect of L-carnitine in acute myocardial ischaemia, the capability of the compound to reduce the extent of necrotic area in patients with a confirmed diagnosis of acute myocardial infarction was evaluated. The effect of L-carnitine was determined using technetium-99m (Tc99m) SPECT (Single Photon Emission Tomography) imaging. L-carnitine was found to significantly increase myocardial viability in treated patients after 8 week’ oral supplementation, in comparison with controls treated with placebo. The data suggest that L-carnitine may have a significant role in the treatment of patients after myocardial infarction.

Keywords

Acute Myocardial Infarction Carnitine Drug Invest Single Photon Emission Tomography Trimetazidine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc 1981; Dec 23: 321Google Scholar
  2. 2.
    Shug AL, Thomsen JH, Folts JD, et al. Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys 1978; 187(1): 25–33PubMedCrossRefGoogle Scholar
  3. 3.
    Shug AL, et al. Changes in carnitine-linked metabolism during ischemia, thermal injury and shock. Carnitine biosynthesis, metabolism and functions. Academic Press Inc: 1980Google Scholar
  4. 4.
    Shug AL, Shrago E, Bihar N. Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am J Physiol 1975; 228: 689PubMedGoogle Scholar
  5. 5.
    Siliprandi D, Biban C, Testa S, et al. Effects of palmitoylCoA and palmitoylcarnitine on the membrane potential and Mg2+ content of rat heart mitochondria. Mol Cell Biochem 1992; 116: 117–23PubMedCrossRefGoogle Scholar
  6. 6.
    Siliprandi N, Di-Lisa F, Toninello A. Biochemical derangements in ischemic myocardium; the role of carnitine. G Ital Cardiol 1984; 14: 804–8PubMedGoogle Scholar
  7. 7.
    Spagnoli LG, Corsi M, Villashi S, et al. Myocardial carnitine deficiency in acute myocardial infarction. Lancet 1982; 1: 1419PubMedCrossRefGoogle Scholar
  8. 8.
    Rizzon P, Biasco G, Di-Biase M, et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Heart J 1989; 10: 502–8PubMedGoogle Scholar
  9. 9.
    Davini P, Bigalli A, Lamanna F, et al. Controlled study on L-carnitine therapeutic efficacy in post-infarction. Drugs Exp Clin Res 1992; 18(8): 355–65PubMedGoogle Scholar
  10. 10.
    Rebuzzi AG, et al. Beneficial effects of L-carnitine in the reduction of the necrotic area in acute myocardial infarction. Drugs Exp Clin Res 1984; 10(4): 219–23Google Scholar
  11. 11.
    Chiariello M, et al. L-carnitine in acute myocardial infarction. A multicenter randomized trial. In: Borum PR, editor. Clinical aspects of carnitine deficiency. New York: Pergamon Press 1986; 242–3Google Scholar
  12. 12.
    Martina B, Zuber M, Weiss P, et al. Antiarrhythmische Behandlung mit L-Carnitine beim akuten Myokardinfarkt. Schweiz Med Wochenschr 1992; 122: 1352–5PubMedGoogle Scholar
  13. 13.
    Beller GA, Sinusas AJ. Experimental studies of the physiologic properties of Technetium-99m isonitriles. Am J Cardiol 1990; 66: 5EPubMedCrossRefGoogle Scholar
  14. 14.
    Pasternak RC, Braunwald E, Burton S. In: Braunwald E, editor. Heart diseases: a textbook of cardiovascular medicine. WB Saunders Co 1992; 2: 1213Google Scholar
  15. 15.
    Taillefer R. Technetium-99m sestamibi myocardial imaging: Same-day rest-stress studies and dipyridamole. Am J Cardiol 1990; 66: 80EPubMedCrossRefGoogle Scholar
  16. 16.
    Siegel S, Castellan NJ Jr. Nonparametric statistics for behavioral sciences. Berkshire: McGraw Hill, 1988: 87–95Google Scholar
  17. 17.
    Rude RE, Muller JE, Braunwald E. Efforts to limit the size of myocardial infarcts. Ann Intern Med 1981; 95: 736PubMedGoogle Scholar
  18. 18.
    Van der Laarse A, Van Leeuwen FF, Kwe R, et al. The size of infarction as judged enzymatically in 1974 patients with AMI: relation with symptomatology infarct localization and type of infarction. Int J Cardiol 1988; 19: 191PubMedCrossRefGoogle Scholar
  19. 19.
    Gutovitz AL, Sobel BE, Roberts R. Progressive nature of myocardial injury in selected patients with cardiogenic shock. Am J Cardiol 1978; 41: 469PubMedCrossRefGoogle Scholar
  20. 20.
    Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m Hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to Thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301PubMedGoogle Scholar
  21. 21.
    Braunwald E, Kloner RA. The stunned myocardium: prolonged post ischemic myocardial ventricular dysfunction. Circulation 1982; 66: 1146PubMedCrossRefGoogle Scholar
  22. 22.
    Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence of hibernating myocardium. J Am Coll Cardiol 1986; 8: 1467PubMedCrossRefGoogle Scholar
  23. 23.
    Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine administration on left ventricular remodelling after acute anterior myocardial infarction — the CEDIM trial, Bari, Italy. J Am Coll Cardiol 1995; 26(2): 380–7PubMedCrossRefGoogle Scholar
  24. 24.
    Idellwenger JA, Grotyohann LW, Neely JR. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 1978 June; 253(12): 4310Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • K. G. C. Jacoba
    • 1
  • R. F. AbarquezJr
    • 1
  • G. O. Topacio
    • 2
  • M. T. Abola
    • 1
  • V. B. Flores
    • 1
  • J. M. Sison
    • 3
  • V. Defensor
    • 2
  • D. Aliwalas
    • 2
  1. 1.Philippine Heart CenterQuezon CityPhilippines
  2. 2.Department of MedicineMedical Center ManilaManilaPhilippines
  3. 3.Medical Corp, Armed Forces of the Philippines Medical CenterQuezon CityPhilippines

Personalised recommendations